1.
Open Forum Infect Dis
; 10(Suppl 1): S13-S16, 2023 May.
Article
in English
| MEDLINE | ID: covidwho-20242217
ABSTRACT
Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance. Four Gavi-supported countries have introduced TCVs since 2018. In the wake of the COVID-19 emergency, momentum is building to scale up TCV introduction worldwide, supported by global partners and Gavi's funding for improved typhoid diagnostics.
2.
Lancet Microbe
; 3(4): e242-e243, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1697918
3.
Vaccine
; 39(49): 7128-7130, 2021 12 03.
Article
in English
| MEDLINE | ID: covidwho-1560581
Subject(s)
COVID-19 Vaccines , COVID-19 , Compensation and Redress , Developing Countries , Humans , SARS-CoV-2
4.
Vaccine
; 2021.
Article
in English
| EuropePMC | ID: covidwho-1489879
5.
Vaccine
; 39(10): 1478-1480, 2021 03 05.
Article
in English
| MEDLINE | ID: covidwho-1071988
6.
Nature
; 587(7833): 197, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-919388